Combinations of Chronic, Physical Illnesses Up the Risk of Subsequent Depression
In the highest-risk groups, roughly one in 12 people developed depression over the next 10 years
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
Accurate Risk Prediction Model Developed for Pediatric Pneumonia
Model can discriminate between mild community-acquired pneumonia and moderate or severe community-acquired pneumonia accurately
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
A wearable pulse oximeter and connected software platform shows patient acceptability in ongoing trials
Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes
Findings compared with both the pre-November 2017 and post-November 2017 eras
FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups
Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth
Pausing Medicaid eligibility determinations during COVID-19 pandemic linked to increased risk for having no prescriptions and cash-pay prescriptions
Mortality Up With Loss of Low-Income Subsidy for Drugs
Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV
Apnea During REM May Affect Brain Regions Related to Memory Consolidation
OSA-related hypoxemia linked to increased frontoparietal cerebrovascular pathology, which is associated with reduced medial temporal lobe integrity
